Annual accounts
Full accounts
30/09/2026Filing deadline
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
Reference data exactly as held at Companies House.
The two filings Companies House requires every year, and where each one stands against its deadline today.
Full accounts
30/09/2026Filing deadline
Confirms the registry record is up to date
The latest figures ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £32.15M
Total Assets
2023: £32.17M
Cash in Bank
2023: £166.10K
Total Liabilities
2023: £30.60K
Employees
2023: 3
Of the 4 measures with an earlier filing to compare against, 3 fell and 1 was unchanged. Cash in bank moved furthest, down 14.84% on 2023. See the full financial analysis for ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED.
The full financial record
Four ways through ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 2 | -1 |
| 2023 | 3 | 0 |
| 2022 | 3 | 0 |
| 2021 | 3 | – |
Reported employee count decreased from 3 in 2021 to 2 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 22/01/2020–21/10/2022 | 13 | |
| Director | 21/08/2015–08/04/2021 | 2 | |
| Director | 17/04/2019–08/04/2021 | 2 | |
| Director | 22/01/2020–12/10/2023 | 14 | |
| Director | 22/01/2020–12/10/2023 | 2 | |
| Secretary | 22/01/2020–Present | 0 | |
| Secretary | 21/08/2015–22/01/2020 | 0 | |
| Director | 12/10/2023–Present | 10 | |
| Director | 12/10/2023–Present | 8 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–22/01/2020 | 2 |
186 UK companies are similar to ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED, sharing the same company status (Active), the same industry sector and activity group (Activities of other holding companies n.e.c.) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
4 Rose Crescent, Cambridge CB2 3LL
Flat 1 Sir Peter Thompson House, 25 Market Close, Poole, Dorset BH15 1NE
111 Park Street, London W1K 7JF
Unit 1 Hilliards Court, Chester Business Park, Chester, Cheshire CH4 9QP
Windsor House, Bayshill Road, Cheltenham, Gloucestershire GL50 3AT
A short description of the company, written from its Companies House record.
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED is a private limited company registered in the United Kingdom, based in 3rd Floor, North & South Wings 100 Longwater Avenue, Green Park, Reading, Berkshire RG2 6GP. Companies House classifies its business as Activities of other holding companies n.e.c.. It has been on the register for 11 years 1 month.
The register currently records it as active. Its 2024 accounts report net assets of £32.14M and 2 employees.
Answered from this company's own registry record and filed figures.
Companies House records ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED under one registered business activity: Activities of other holding companies n.e.c. (64.20/9 - SIC 2007).
ICON CLINICAL RESEARCH (U.K.) NO. 6 LIMITED is recorded as active on the Companies House register, and has been on it since 21/08/2015.
The most recent accounts Okredo holds cover 2024 and report net assets of £32.14M, total assets of £32.15M, cash in bank of £141.44K and total liabilities of £10.14K.
On the current registry record, accounts are due by 30/09/2026.
Companies House lists 9 officers (3 currently in post) and 1 person with significant control (0 current).